List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Viral Vectors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vectors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vectors Overall Market Size
2.1 Global Viral Vectors Market Size: 2022 VS 2030
2.2 Global Viral Vectors Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vectors Players in Global Market
3.2 Top Global Viral Vectors Companies Ranked by Revenue
3.3 Global Viral Vectors Revenue by Companies
3.4 Top 3 and Top 5 Viral Vectors Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral Vectors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Vectors Players in Global Market
3.6.1 List of Global Tier 1 Viral Vectors Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vectors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vectors Market Size Markets, 2022 & 2030
4.1.2 Retroviral Vectors
4.1.3 Lentiviral Vectors
4.1.4 Adenoviral Vectors
4.1.5 Herpes Simplex Virus Vectors
4.1.6 Chimeric Viral Vectors
4.1.7 Others
4.2 By Type - Global Viral Vectors Revenue & Forecasts
4.2.1 By Type - Global Viral Vectors Revenue, 2018-2023
4.2.2 By Type - Global Viral Vectors Revenue, 2024-2030
4.2.3 By Type - Global Viral Vectors Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vectors Market Size, 2022 & 2030
5.1.2 Cancers
5.1.3 Inherited Disorders
5.1.4 Viral Infections
5.1.5 Others
5.2 By Application - Global Viral Vectors Revenue & Forecasts
5.2.1 By Application - Global Viral Vectors Revenue, 2018-2023
5.2.2 By Application - Global Viral Vectors Revenue, 2024-2030
5.2.3 By Application - Global Viral Vectors Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Viral Vectors Market Size, 2022 & 2030
6.2 By Region - Global Viral Vectors Revenue & Forecasts
6.2.1 By Region - Global Viral Vectors Revenue, 2018-2023
6.2.2 By Region - Global Viral Vectors Revenue, 2024-2030
6.2.3 By Region - Global Viral Vectors Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Viral Vectors Revenue, 2018-2030
6.3.2 US Viral Vectors Market Size, 2018-2030
6.3.3 Canada Viral Vectors Market Size, 2018-2030
6.3.4 Mexico Viral Vectors Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Viral Vectors Revenue, 2018-2030
6.4.2 Germany Viral Vectors Market Size, 2018-2030
6.4.3 France Viral Vectors Market Size, 2018-2030
6.4.4 U.K. Viral Vectors Market Size, 2018-2030
6.4.5 Italy Viral Vectors Market Size, 2018-2030
6.4.6 Russia Viral Vectors Market Size, 2018-2030
6.4.7 Nordic Countries Viral Vectors Market Size, 2018-2030
6.4.8 Benelux Viral Vectors Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Viral Vectors Revenue, 2018-2030
6.5.2 China Viral Vectors Market Size, 2018-2030
6.5.3 Japan Viral Vectors Market Size, 2018-2030
6.5.4 South Korea Viral Vectors Market Size, 2018-2030
6.5.5 Southeast Asia Viral Vectors Market Size, 2018-2030
6.5.6 India Viral Vectors Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Viral Vectors Revenue, 2018-2030
6.6.2 Brazil Viral Vectors Market Size, 2018-2030
6.6.3 Argentina Viral Vectors Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Vectors Revenue, 2018-2030
6.7.2 Turkey Viral Vectors Market Size, 2018-2030
6.7.3 Israel Viral Vectors Market Size, 2018-2030
6.7.4 Saudi Arabia Viral Vectors Market Size, 2018-2030
6.7.5 UAE Viral Vectors Market Size, 2018-2030
7 Viral Vectors Companies Profiles
7.1 BioReliance
7.1.1 BioReliance Company Summary
7.1.2 BioReliance Business Overview
7.1.3 BioReliance Viral Vectors Major Product Offerings
7.1.4 BioReliance Viral Vectors Revenue in Global Market (2018-2023)
7.1.5 BioReliance Key News & Latest Developments
7.2 Cobra Biologics
7.2.1 Cobra Biologics Company Summary
7.2.2 Cobra Biologics Business Overview
7.2.3 Cobra Biologics Viral Vectors Major Product Offerings
7.2.4 Cobra Biologics Viral Vectors Revenue in Global Market (2018-2023)
7.2.5 Cobra Biologics Key News & Latest Developments
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Company Summary
7.3.2 Oxford BioMedica Business Overview
7.3.3 Oxford BioMedica Viral Vectors Major Product Offerings
7.3.4 Oxford BioMedica Viral Vectors Revenue in Global Market (2018-2023)
7.3.5 Oxford BioMedica Key News & Latest Developments
7.4 UniQure
7.4.1 UniQure Company Summary
7.4.2 UniQure Business Overview
7.4.3 UniQure Viral Vectors Major Product Offerings
7.4.4 UniQure Viral Vectors Revenue in Global Market (2018-2023)
7.4.5 UniQure Key News & Latest Developments
7.5 FinVector
7.5.1 FinVector Company Summary
7.5.2 FinVector Business Overview
7.5.3 FinVector Viral Vectors Major Product Offerings
7.5.4 FinVector Viral Vectors Revenue in Global Market (2018-2023)
7.5.5 FinVector Key News & Latest Developments
7.6 MolMed
7.6.1 MolMed Company Summary
7.6.2 MolMed Business Overview
7.6.3 MolMed Viral Vectors Major Product Offerings
7.6.4 MolMed Viral Vectors Revenue in Global Market (2018-2023)
7.6.5 MolMed Key News & Latest Developments
7.7 MassBiologics
7.7.1 MassBiologics Company Summary
7.7.2 MassBiologics Business Overview
7.7.3 MassBiologics Viral Vectors Major Product Offerings
7.7.4 MassBiologics Viral Vectors Revenue in Global Market (2018-2023)
7.7.5 MassBiologics Key News & Latest Developments
7.8 Richter-Helm
7.8.1 Richter-Helm Company Summary
7.8.2 Richter-Helm Business Overview
7.8.3 Richter-Helm Viral Vectors Major Product Offerings
7.8.4 Richter-Helm Viral Vectors Revenue in Global Market (2018-2023)
7.8.5 Richter-Helm Key News & Latest Developments
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Major Product Offerings
7.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors Revenue in Global Market (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.10 Lonza
7.10.1 Lonza Company Summary
7.10.2 Lonza Business Overview
7.10.3 Lonza Viral Vectors Major Product Offerings
7.10.4 Lonza Viral Vectors Revenue in Global Market (2018-2023)
7.10.5 Lonza Key News & Latest Developments
7.11 Aldevron
7.11.1 Aldevron Company Summary
7.11.2 Aldevron Business Overview
7.11.3 Aldevron Viral Vectors Major Product Offerings
7.11.4 Aldevron Viral Vectors Revenue in Global Market (2018-2023)
7.11.5 Aldevron Key News & Latest Developments
7.12 Eurogentec
7.12.1 Eurogentec Company Summary
7.12.2 Eurogentec Business Overview
7.12.3 Eurogentec Viral Vectors Major Product Offerings
7.12.4 Eurogentec Viral Vectors Revenue in Global Market (2018-2023)
7.12.5 Eurogentec Key News & Latest Developments
7.13 Cell and Gene Therapy Catapult
7.13.1 Cell and Gene Therapy Catapult Company Summary
7.13.2 Cell and Gene Therapy Catapult Business Overview
7.13.3 Cell and Gene Therapy Catapult Viral Vectors Major Product Offerings
7.13.4 Cell and Gene Therapy Catapult Viral Vectors Revenue in Global Market (2018-2023)
7.13.5 Cell and Gene Therapy Catapult Key News & Latest Developments
7.14 Biovian
7.14.1 Biovian Company Summary
7.14.2 Biovian Business Overview
7.14.3 Biovian Viral Vectors Major Product Offerings
7.14.4 Biovian Viral Vectors Revenue in Global Market (2018-2023)
7.14.5 Biovian Key News & Latest Developments
7.15 Thermo Fisher Scientific (Brammer Bio)
7.15.1 Thermo Fisher Scientific (Brammer Bio) Company Summary
7.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
7.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Major Product Offerings
7.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific (Brammer Bio) Key News & Latest Developments
7.16 VGXI
7.16.1 VGXI Company Summary
7.16.2 VGXI Business Overview
7.16.3 VGXI Viral Vectors Major Product Offerings
7.16.4 VGXI Viral Vectors Revenue in Global Market (2018-2023)
7.16.5 VGXI Key News & Latest Developments
7.17 PlasmidFactory
7.17.1 PlasmidFactory Company Summary
7.17.2 PlasmidFactory Business Overview
7.17.3 PlasmidFactory Viral Vectors Major Product Offerings
7.17.4 PlasmidFactory Viral Vectors Revenue in Global Market (2018-2023)
7.17.5 PlasmidFactory Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
